Safety Outcomes and Infectious Complications Following Yttrium-90 Radioembolization in Patients with Prior Biliary Interventions: A Comprehensive Review
Background: Yttrium-90 radioembolization (Y-90) is an established locoregional therapy for primary and metastatic liver malignancies. Patients with prior biliary intervention may face a higher risk of infectious complications because of altered biliary anatomy and bacterial colonization. Objective: To evaluate the incidence of infectious complications after Y-90 radioembolization in patients with prior biliary intervention. Methods: PubMed, Embase, and Scopus were searched from inception to June 2026, and risk of bias was assessed for each study. Studies were synthesized descriptively, with per-study proportions and crude totals that count overlapping patients once. Results: Eight studies were included: six retrospective cohorts and two case reports. Four cohorts reported per-patient outcomes in 152 patients; one reported only per procedure, and another was a subset of a larger cohort. Hepatobiliary infection (liver abscess or cholangitis) occurred in 12 of 152 patients (7.9%), liver abscess in 10 (6.6%), cholangitis in 5 (3.3%), and sepsis with hepatobiliary infection in 8 (5.3%); 2 patients died of infection (1.3%). Conclusion: Hepatobiliary infection after Y-90 radioembolization in patients with prior biliary intervention appears less frequent than reported after chemoembolization but more frequent than with intact biliary anatomy. Radioembolization may be a reasonable option in this population.
Authors
- Ahmed Kamel Abdel Aal (ORCID: https://orcid.org/0000-0003-3170-6180)
- John Moody
- Abin Sajan (ORCID: https://orcid.org/0000-0002-4299-5320)
- Kirema Garcia-Reyes (ORCID: https://orcid.org/0000-0002-9877-1334)
- Zachary T. Berman (ORCID: https://orcid.org/0000-0002-8651-9772)
- Tyler Allan Sandow (ORCID: https://orcid.org/0000-0002-5788-7357)
- Venkatesh P. Krishnasamy (ORCID: https://orcid.org/0000-0002-2644-9987)
- Shamar J Young (ORCID: https://orcid.org/0000-0002-7967-7166)
- Kiyon Naser-Tavakolian (ORCID: https://orcid.org/0000-0003-2193-485X)
- Junaid Y. Raja (ORCID: https://orcid.org/0000-0002-6223-7244)
- Tarub S. Mabud (ORCID: https://orcid.org/0000-0002-0192-2395)
- Shams I. Iqbal
- Areeb Siddiqui
Institutions
- University of North Carolina at Chapel Hill (US)
- Ochsner Health System (US)
- Harvard University (US)
- University of Arizona (US)
- Johns Hopkins University (US)
- Columbia University Irving Medical Center (US)
- Ochsner Medical Center (US)
- Johns Hopkins Medicine (US)
- University of Alabama at Birmingham (US)
- University of California San Diego (US)
- Massachusetts General Hospital (US)
- The University of Texas Health Science Center at Houston (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Current Oncology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3390/curroncol33110715
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00